FRIDAY, June 20, 2025 -- People undergoing metabolic and bariatric surgery (MBS) are less likely to develop psychiatric disorders than those treated...
Vous n'êtes pas connecté
MONDAY, June 23, 2025 -- For adults with obesity or overweight without diabetes, the novel cyclic adenosine monophosphate-biased glucagon like peptide 1 receptor agonist, ecnoglutide, yields a superior and sustained reduction in body weight versus...
FRIDAY, June 20, 2025 -- People undergoing metabolic and bariatric surgery (MBS) are less likely to develop psychiatric disorders than those treated...
FRIDAY, June 20, 2025 -- People undergoing metabolic and bariatric surgery (MBS) are less likely to develop psychiatric disorders than those treated...
Bagsværd, Denmark, 21 June 2025 – Novo Nordisk today presented the results from the phase 3b STEP UP trial in people with obesity without...
Bagsværd, Denmark, 21 June 2025 – Novo Nordisk today presented the results from the phase 3b STEP UP trial in people with obesity without...
Tirzepatide and GLP-1 receptor agonists are replacing older treatments, marking a shift in how diabetes and weight loss are managed.
A recent study reveals that nearly 20% of Indian households have all adults classified as overweight, while 10% are obese. States like Manipur and...
A recent study reveals that nearly 20% of Indian households have all adults classified as overweight, while 10% are obese. States like Manipur and...
Metformin shows promise in reducing knee osteoarthritis pain in overweight individuals and delaying surgery.
bGlucagon-like peptide-1 receptor agonists/b (GLP-1RAs), a class of drugs commonly prescribed for type 2 diabetes, bimprove cardiovascular...
bGlucagon-like peptide-1 receptor agonists/b (GLP-1RAs), a class of drugs commonly prescribed for type 2 diabetes, bimprove cardiovascular...